DHA Algal‑Oil Incorporation Strategies And Stability Challenges in Infant Complementary Foods And Liquid Dairy Products

Driven by market demand for precision infant nutrition, DHA algal oil is now widely incorporated beyond traditional soft‑capsule and drop formats into ready‑to‑drink liquid milk, ambient‑stable dairy, complementary‑food purées, infant rice cereals, melt‑in‑mouth puffed snacks and nutritional beverages. Unlike simple capsule matrices, complementary foods and liquid‑dairy systems are water‑based, subjected to high‑temperature processing and expected to sustain long ambient shelf‑lives, presenting substantial hidden technical hurdles for DHA algal‑oil deployment.

Many brand owners and procurement teams focus exclusively on raw‑material DHA titre, fatty‑acid ratios and unit cost while neglecting processing compatibility and shelf‑life stability. Consequences include finished‑product phase separation, oil creaming, aggravated fishy off‑notes, excessive DHA degradation and non‑compliant nutritional assay results, triggering quality‑control and after‑sales complications.

This article addresses both consumer and industrial stakeholders. It explains compliant incorporation frameworks, process‑compatibility logic, core stability bottlenecks and proven industry mitigation strategies for DHA algal oil within infant complementary foods and liquid dairy. It helps consumers interpret product‑quality distinctions and enables procurement and R&D teams to avoid sourcing and manufacturing pitfalls, accompanied by authoritative scientific references.

1. Regulatory‑Compliant DHA Incorporation Principles for Infant Complementary Foods & Liquid Dairy

DHA addition into infant foods cannot be arbitrary and must strictly follow national‑standard requirements, representing non‑negotiable foundational boundaries for product commercialisation.

Per GB 10765‑2021 Infant Formula and GB 10766‑2021 Follow‑up Formula for Older Infants and Young Children: whenever DHA is added to liquid‑milk and formula‑dairy products, ARA shall be co‑added and ARA content shall be no lower than DHA content. The optimal DHA‑to‑ARA ratio approximates human‑milk proportions of 1:1 ~ 1:1.7, preventing fatty‑acid metabolic imbalance caused by DHA‑only fortification. National standards also impose upper limits for DHA addition to avoid nutritional imbalance and amplified oxidation risk from over‑dosage.

For complementary‑food categories, national regulations permit DHA‑algal‑oil fortification in infant grain‑based complementary foods, fruit‑vegetable purées, meat purées and snack‑style complementary foods. Mandatory ARA pairing is not enforced for these items. Nutritionally, however, ARA co‑fortification delivers superior nutritional completeness and constitutes mainstream formulation practice within premium complementary‑food lines.

Regarding dosage, the industry‑accepted safe operational benchmark specifies 3‑10 mg DHA per 100 kJ for liquid‑milk systems. For infant complementary foods, active DHA dosage is controlled per serving size, aligned with Chinese dietary reference intakes for infants to balance nutritional efficacy and food safety.

Three major raw‑material options prevail for different application scenarios:

• Refined liquid algal oil: suited for low‑temperature complementary foods and post‑spray‑on processes.
• Microencapsulated DHA algal‑oil powder: high thermal tolerance and enhanced stability, for high‑temperature baked and extruded complementary‑food items.
• Structured‑triglyceride‑based compound emulsions: deployed in liquid milk and ambient‑stable beverages to resolve oil‑water incompatibility, creaming and phase separation; currently a premium solution for liquid nutritional products.

2. Four Core Stability Challenges for DHA Algal Oil within Aqueous Matrices

DHA algal oil consists of highly unsaturated lipophilic lipids with high chemical reactivity. Liquid milk and fluid complementary foods are water‑continuous systems subjected to pasteurisation / UHT sterilisation, homogenisation, filling and prolonged ambient storage. Combined process stresses frequently induce stability failure, representing pervasive technical pain‑points across the sector.

2.1. Oil‑water incompatibility: phase separation, oil creaming and sedimentation. DHA algal oil is water‑insoluble. Direct addition without dedicated emulsification rapidly yields a surface oil layer, creaming and visible phase separation. Beyond aesthetic defects, this generates heterogeneous DHA distribution unit‑to‑unit and batch‑to‑batch: DHA accumulates in upper oil fractions while lower layers are DHA‑depleted. This creates regulatory non‑compliance risks during official sampling and compositional testing, a frequent quality defect in low‑end liquid DHA‑fortified complementary foods.

2.2. High thermal susceptibility: oxidative degradation under thermal processing. Multiple double‑bonds render DHA extremely heat‑labile. Unit‑operations essential for liquid‑milk manufacturing (pasteurisation, UHT ultra‑high‑temperature sterilisation), alongside complementary‑food baking and drying steps, accelerate DHA oxidative decomposition. Poor‑stability raw materials lacking encapsulation protection suffer severe post‑processing DHA loss. Products may satisfy specification at release yet degrade out‑of‑spec across shelf‑life, concurrently generating rancid compounds and amplifying fishy off‑flavours.

2.3. Shelf‑life oxidative deterioration: rising acid value and peroxide value. Within aqueous food matrices, algal‑oil surfaces exposed to oxygen and moisture are greatly expanded compared with oil‑filled capsules, accelerating oxidation. During prolonged ambient storage, primary and secondary oxidation reactions proceed continuously, elevating POV and AV. DHA nutritional potency vanishes and aldehyde‑ketone harmful metabolites form, compromising infant food safety and truncating shelf‑life.

2.4. Sensory deterioration: development of fishy and rancid off‑notes. Even mild DHA oxidation releases pronounced fishy‑rancid odours. Infants possess sensitive taste perception, frequently leading to feeding refusal. Poor end‑user experience and low repurchase rates for certain DHA‑fortified complementary foods and liquid‑milk goods often originate from DHA oxidation rather than base‑formulation deficiencies.

3. Established Industrial Stability‑Improving Solutions (Operational Reference for Procurement & Manufacturing Plants)

Responsible food manufacturers address the above challenges via four interconnected pillars: raw‑material selection, emulsification engineering, encapsulation technology and production‑workflow governance. These criteria also enable procurement teams to evaluate supply‑chain competence and screen high‑quality product offerings.

3.1. Application‑oriented raw‑material selection. For high‑temperature‑processed complementary foods (rice cereals, melt‑in‑mouth snacks, biscuits), prioritise microencapsulated DHA algal‑oil powder utilising maltodextrin, gum arabic or sodium caseinate as shell material. Encapsulation physically isolates lipid payload from heat and oxygen, conferring thermal robustness for thermal manufacturing workflows. For ambient‑stable liquid milk and fluid complementary foods, select nano‑scale compound DHA emulsions. High‑pressure homogenisation breaks lipids down into micro‑sized dispersed particles, achieving oil‑water compatibility, homogeneous dispersion and suppression of creaming‑separation defects.

3.2. Optimised emulsification systems stabilising oil‑water equilibrium. DHA‑containing lipid systems favour an HLB (hydrophile‑lipophile balance) value near 11.3. Single emulsifiers deliver insufficient stability; industry standard practice employs compound‑emulsifier blends combining distilled monoglycerides with polysorbate‑series surfactants at scientifically optimised ratios. This drastically improves emulsion stability, resists demulsification‑separation through sterilisation and shelf‑life, and maintains uniform DHA dispersion throughout the food matrix.

3.3. Process optimisation to mitigate processing‑related nutrient losses. Deploy post‑addition under low‑temperature conditions: introduce DHA after high‑temperature sterilisation or baking cycles to minimise thermal degradation. Control high‑pressure homogenisation pressure within 30‑40 MPa to generate fine, uniform lipid droplets and enhance matrix stability. Enforce light‑proof, sealed, cool conditions throughout manufacturing and warehousing to reduce oxidation triggers.

3.4. Govern fatty‑acid ratios and antioxidant systems. Adopt human‑milk‑aligned DHA‑to‑ARA ratios of 1:1 ~ 1:1.7. ARA's superior structural stability counteracts DHA oxidative propensity. Add permitted food‑grade antioxidant adjuvants to suppress polyunsaturated‑lipid oxidation, stabilise acid‑value and peroxide‑value parameters and maintain full‑shelf‑life compliance.

4. Consumer Shopping Guidance & Procurement Quality‑Control Key Points

For Consumers

Deep process‑knowledge is unnecessary. Follow simple practical shopping rules:

• Prefer DHA‑fortified complementary foods and liquid dairy showing no phase separation, no free surface oil and mild, non‑rancid sensory profiles.
• Avoid low‑cost products listing crude algal oil without noted emulsification or encapsulation processing.
• Select legitimate products applying scientifically balanced DHA+ARA ratios and declaring guaranteed‑shelf‑life active‑nutrient content, avoiding inferior goods featuring heavy processing losses and in‑storage nutrient deactivation.

For Procurement, Brand‑Owners and Channel Distributors

Build formalised risk‑control frameworks:

• Do not judge suppliers purely on raw‑material unit price. Evaluate application‑specific compatibility; clearly differentiate use‑cases for powder, emulsion and neat‑oil formats to prevent quality failures caused by mis‑specification.
• Request shelf‑life stability study reports reviewing DHA retention rate and AV‑POV drift across the labelled shelf‑life, mitigating late‑stage deterioration risks.
• Strictly observe national‑standard fatty‑acid‑ratio rules and reject DHA‑mono‑fortified formulations to guarantee regulatory nutritional compliance.
• Source from supply‑chains with proven mature emulsification and encapsulation capabilities, resolving industry pain‑points of separation, oxidation and poor sensory quality at source, strengthening product market competitiveness and end‑consumer reputation.

The primary technical challenge of incorporating DHA algal oil into infant complementary foods and liquid‑dairy matrices lies not in simple formula addition, but in real‑world technical delivery of water‑matrix compatibility, heat resistance, antioxidative performance and long‑term stability. Neat algal oil is ill‑suited for liquid and high‑temperature‑processing environments and readily exhibits creaming‑separation, nutrient degradation, oxidative off‑flavours and out‑of‑spec analytical results.

Only through scenario‑tailored raw‑material selection, scientifically designed emulsification‑encapsulation technology, standardised production governance and compliant formulation architecture can full DHA nutrient retention, consistent product quality and assured food safety be achieved. Understanding stability‑related common knowledge helps consumers evade inferior complementary‑food offerings. Mastering process and risk‑control logic enables procurement stakeholders to lower product‑related after‑sales exposure and develop differentiated premium nutritional products.

References

[1] National Health Commission of PRC. GB 10765‑2021, National Food Safety Standard: Infant Formula [S]. Beijing: People's Medical Publishing House, 2021.

[2] National Health Commission of PRC. GB 10766‑2021, National Food Safety Standard: Follow‑up Formula for Older Infants and Young Children [S]. Beijing: People's Medical Publishing House, 2021.

[3] Chinese Nutrition Society. Chinese Dietary Reference Intakes (2023 Edition) [M]. Beijing: People's Medical Publishing House, 2023.

[4] Yang Yuexin. Chinese Encyclopedia of Nutrition Science (2nd Edition) [M]. Beijing: People's Medical Publishing House, 2019.

[5] Yu Chenghua. Detection and quality‑risk analysis of polyunsaturated fatty acids in foods [J]. Journal of Food Safety & Quality, 2025.

[6] He Guanghua, Liu Ning. Research on fatty‑acid distribution characteristics at sn‑2 position of human‑milk triglycerides [J]. Journal of Chinese Institute of Food Science and Technology, 2019.

[7] Bazinet R P, Layé S. Docosahexaenoic and arachidonic acid as neuroprotective nutrients throughout the life cycle [J]. Nutrients, 2021,13(11):4001.

[8] Food Industry Science and Technology. Research on application of DHA microencapsulation technology in liquid dairy products [J]. Science and Technology of Food Industry, 2024.

[9] FDA. GRN No.862. Generally Recognized As Safe Notice for Algal Oil [R]. 2020.